Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

Na minha lista:
書目詳細資料
發表在:Oncotarget
Main Authors: Cazzaniga, Marina, Verusio, Claudio, Ciccarese, Mariangela, Fumagalli, Alberto, Sartori, Donata, Valerio, Maria Rosaria, Airoldi, Mario, Moretti, Gabriella, Ficorella, Corrado, Arcangeli, Valentina, Diodati, Lucrezia, Zambelli, Alberto, Febbraro, Antonio, Generali, Daniele, Pistelli, Mirco, Garrone, Ornella, Musolino, Antonino, Vici, Patrizia, Maur, Michela, Mentuccia, Lucia, La Verde, Nicla, Bianchi, Giulia, Artale, Salvatore, Blasi, Livio, Piezzo, Matilde, Atzori, Francesco, Turletti, Anna, Benedetto, Chiara, Cursano, Maria Concetta, Fabi, Alessandra, Gebbia, Vittorio, Schirone, Alessio, Palumbo, Raffaella, Ferzi, Antonella, Frassoldati, Antonio, Scavelli, Claudio, Clivio, Luca, Torri on behalf of The EVA Study Group, Valter
格式: Artigo
語言:Inglês
出版: Impact Journals LLC 2018
主題:
Correction
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6195381/
https://ncbi.nlm.nih.gov/pubmed/30349655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26213
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍